TNF and COVID-19: Induction of CD39 expression occurs upon cellular activation and is regulated by hypoxia, oxidative stress, and inflammatory cytokines such as IL-6 and TNF-α (41, 44–46), which are frequently increased in COVID-19 patients (47–50).